GUARDANT HEALTH has partnered with SWOG on a study to use cell-free DNA testing to identify mechanisms of resistance and future treatment options in non-small cell lung cancer. SWOG chose Guardant360 as the blood test for a tumor genomic profiling study of approximately 600 lung cancer patients. The study will test patients at the time...
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
